Analysis of philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization

Annals of Oncology

Volumn 10, Issue 8, 1999, Pages 955-959

  Seong, D ^b   Kantarjian, H M ^a   Albitar, M ^a   Arlinghaus, R ^a   Xu, J ^a   Talpaz, M ^a   Rios, M B ^a   Qiang Guo, J ^a   O'Brien, S ^a   Siciliano, M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Sam Sung Jeil Hospital   (South Korea)

Author keywords

Chronic myelogenous leukemia; FISH; Fluorescent in situ hybridization; Philadelphia chromosome negative

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; BUSULFAN; CYTARABINE; GAMMA INTERFERON; HYDROXYUREA;

ADULT; ARTICLE; BONE MARROW CULTURE; CANCER COMBINATION CHEMOTHERAPY; CHROMOSOME 22Q; CHROMOSOME 9Q; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; MALE; METAPHASE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

ADULT; BLOTTING, SOUTHERN; BONE MARROW CELLS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-NEGATIVE; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; SENSITIVITY AND SPECIFICITY;

EID: 0032834443     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008349405763     Document Type: Article

References (21)

1. Groffen J, Stephenson JR, Heisterkamp N et al. Philadelphia chromosomal breakpoints are clustered within a limited region bcr on chromosome 22. Cell 1994: 36: 93-9.
2. Sandberg AA, Gemmill RM, Hecht BK, Hecht F. The Philadelphia chromosome a model of cancer and molecular cytogenetics. Cancer Genet Cytogenet 1986: 21: 129-46.
3. Stam K, Heisterkamp N, Grosveld G et al. Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. N Engl J Med 1985: 31: 1429.
4. Konopka JB, Watanave SM, Witte ON. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 1984: 37: 1035.
5. ABL tyrosine protein kinase activity in various subtypes of Philadelphia chromosome positive cells from chronic myelogenous leukemia patients. Cancer Res 1987: 47: 1731.
6. Kantarjian HM, Smith TL, McCredie KB et al. Chronic myelogenous leukemia: A multivariate analysis fo the associations of patient characteristics and therapy with survival. Blood 1985: 66: 1326.
7. Bartram CR, de Klein A, Hagemeijer A et al. Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature 1983: 306: 277.
8. Kantarjian HM, Walters RS, McCredie KB et al. Clinical and prognostic features of Philadelphia chromosome negative chronic myelogenous leukemia. Cancer 1986: 58: 2023.
9. Seong D, Kantarjian H, Ro J et al. Hypermetaphase FISH for quantitative monitoring of Ph-positive cells in patients with CML during treatment. Blood 1995: 86: 2343-9.
10. Trujillo JM, Cork A, Ahearn MJ eT al. Hematologic and cytologic characterization of 8/21 translocation in acute granulocytic leukemia. Blood 1979: 53: 695.
11. Verschraegen C, Talpaz M, Hersh-Ginsberg C et al. Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia. Blood 1995: 85: 2704-10.
12. Guo J, Lian J, Xian Y et al. BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy. Blood 1994: 83: 3629-37.
13. Seong DC, Song MY, Henske EP et al. Analysis of interphase cells for the Philadelphia translocation using painting probe made by inter-alu polymerase chain reaction from a radiation hybrid. Blood 1994: 83: 2268-73.
14. Liu P, Siciliano J, Seong D et al. Dual Alu-PCR primers and conditions for isolation of human chromosome painting probes from hybrid cells. Cancer Genet Cytogenet 1993: 65: 93.
15. Seong D, Liu P, Siciliano J et al. Detection of variant Ph-positive CML involving chromosomes 1, 9 and 22 by FISH. Cancer Genet Cytogenet 1993; 65: 100.
16. Kurzrock R, Gutterman JU, Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 1988: 319: 990.
17. Kurzrock R, Shtalrid M, Gutterman JU, Talpaz M. The molecular diagnostics of chronic myelogenous leukemia and Philadelphia-positive acute leukemia. Cancer Cells 1989: 7: 9.
18. Bartram CR, Kleihauer E, de Klein A et al. c-abl and bcr are rearranged in a Ph-negative CML patient. EMBO J 1985: 4: 683.
19. Rassool F, Sparks RS, Klisak I et al. Do oncogenes determine clinical features in chronic myeloid leukemia? Lancet 1987: 1: 1402.
20. Van der Plas DC, Hermans ABC, Soekarman D et al. Cytogenetic and molecular analysis in Philadelphia-negative CML. Blood 1989: 73: 1038.
21. Kurzrock R, Kantarjian H, Shtalrid M et al. Ph-negative CML without breakpoint cluster region rearrangement: A CML with a distinct clinical course. Blood 1990: 75: 445-52.